NeoGenomics Finance; Genetic Link for Female Orgasm

NeoGenomics, a Fort Myers, Fla.-based clinical testing services laboratory whose stock trades over the counter, on Wednesday announced a $5 million financing arrangement with Cornell Capital Partners. Under the agreement, NeoGenomics has an option to sell Cornell Partners shares of common stock based on discount to a five-day average price with a 5-percent fee on each transaction. NeoGenomics executives said in a statement that the deal was created to provide access to capital for mergers and acquisitions in a market where three of the top 10 genetics laboratories have been acquired in the last year.

An Associated Press article widely published today covers a study by British scientists published in the journal Biology Letters. In the study, the scientists said they were able to establish a biological, or genetic, causality for a woman's ability to achieve orgasm, as opposed to widely held beliefs that disfunction in this has an environmental or cultural underpinning. The research was based on questioning more than 3,500 adult female twins. A total of 683 pairs of identical twins and 714 pairs of non-identical twins, aged between 19 and 83, took part in the study, replying by anonymous questionnaire. A total of 31 percent of the identical twins said they always or frequently attained orgasm during intercourse and 39 percent said they climaxed during masturbation. This compared with only 10 per cent and 17 per cent among non-identical twins. If the genes involved could be identified, this could be a potential pharmaceutical target.

Healthcare Conferences:
-- Thomas Weisel Partners Growth Forum 7.0, San Francisco, June 13-15, 2005
-- Goldman Sachs 26th Annual Global Health Care Conference, Dana Point, Calif., June 13-16, 2005